-

BTIG Franchise Sales Adds Healthcare Specialists Bruce Mackle and Dr. Sean Alyeshmerni

NEW YORK--(BUSINESS WIRE)--BTIG announced today the appointments of Bruce Mackle as Managing Director and Sean Alyeshmerni, D.O. as Director within its Franchise Sales team. Both will focus on expanding and strengthening BTIG’s client relationships within the healthcare sector.

Bruce Mackle brings over 25 years of healthcare-dedicated financial industry experience on the sell-side, buy-side, and as an investor relations advisor. Over the course of his career at firms including Wells Fargo, UBS, and HSBC, Mr. Mackle primarily served as a healthcare trading desk analyst and a healthcare sector sales specialist. Most recently, he worked at LifeSci Advisors, a life science-focused investor relations advisory firm, managing a client portfolio of both public and pre-IPO companies. Mr. Mackle’s buy-side experience includes positions with two healthcare-dedicated funds. He began his career as a healthcare equity research analyst at Gruntal & Co. and UBS.

Prior to joining BTIG, Sean Alyeshmerni, D.O., was a Biotech Investor at CORR Capital, an emerging biotechnology-focused long/short fund. Earlier in his career, he served as Vice President, Investment Banking at Citigroup, specializing in healthcare M&A and capital markets transactions. Dr. Alyeshmerni also held investment roles at Alera Partners and Ditch Plains Capital. He began his career as a physician, completing residencies in Internal Medicine and Psychiatry.

“We are thrilled to welcome Bruce and Sean to BTIG,” said Chris Rollins, BTIG’s Global Co-Head of Securities. “Their vast experience and deep industry connections will bring immediate value to our clients and further enhance BTIG’s presence in healthcare.”

BTIG’s Franchise Sales unit is comprised of a team of nearly 20 seasoned industry professionals fluent in the firm’s multi-product offering. Their expertise helps institutional and corporate clients solve their most important investment decisions and navigate the marketplace across periods of great volatility and stability respectively. BTIG’s Franchise Sales team members are based in Boston, Dallas, London, Miami, Minneapolis, and New York.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 20 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities. The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclaimer

Contacts

Media:
Jill Gordon
443.668.2055
jgordon@prosek.com

Vanessa Siderow
212.738.6148
vsiderow@btig.com

BTIG


Release Versions

Contacts

Media:
Jill Gordon
443.668.2055
jgordon@prosek.com

Vanessa Siderow
212.738.6148
vsiderow@btig.com

More News From BTIG

BTIG Names Arin Prisand as Head of Corporate Access

NEW YORK--(BUSINESS WIRE)--BTIG announced today the appointment of Arin Prisand as Head of Corporate Access. Ms. Prisand will be responsible for leading BTIG’s robust Corporate Access program and delivering innovative, value-added opportunities that foster meaningful connections between investors and corporate clients. "Arin’s dynamic background across trading, research sales, and corporate access makes her well-positioned to further elevate BTIG’s platform,” said Christopher Rollins, Global Co...

BTIG Expands Research Coverage with Appointment of Alex Kania in Utilities and Power

NEW YORK--(BUSINESS WIRE)--BTIG announced today the appointment of Alex Kania as a Managing Director and Senior Research Analyst focused on Utilities and Power Research. This new sector coverage reflects BTIG’s continued investment in research talent and resources, further expanding the firm’s energy and infrastructure practice. Mr. Kania will spearhead coverage of electric, natural gas and water utilities— providing actionable insights to institutional investors navigating today’s evolving ene...

BTIG to Host Virtual Biotechnology Conference on July 29-30, 2025

NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will hold its annual Biotechnology Conference on Tuesday, July 29th through Wednesday, July 30th, 2025. The virtual event will host over 70 established and emerging healthcare company management teams for one-on-one investor meetings and thematic panel discussions with industry leaders. Panel themes will include lupus, pulmonary hypertension, emerging trends in inflammatory bowel disease and irritable bowel syndrome, latest developments in...
Back to Newsroom